ID   COMI
AC   CVCL_A1YL
DR   Wikidata; Q105506716
RX   PubMed=19276180;
RX   PubMed=24443327;
CC   Group: Cancer stem cell line.
CC   Doubling time: 60 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=19276180; DOI=10.1158/1541-7786.MCR-08-0409;
RA   Ropolo M., Daga A., Griffero F., Foresta M., Casartelli G., Zunino A.,
RA   Poggi A., Cappelli E., Zona G., Spaziante R., Corte G., Frosina G.;
RT   "Comparative analysis of DNA repair in stem and nonstem glioma cell
RT   cultures.";
RL   Mol. Cancer Res. 7:383-392(2009).
//
RX   PubMed=24443327; DOI=10.1002/ijc.28680;
RA   Vecchio D., Daga A., Carra E., Marubbi D., Baio G., Neumaier C.E.,
RA   Vagge S., Corvo R., Brisigotti M.P., Ravetti J.L., Zunino A.,
RA   Poggi A., Mascelli S., Raso A., Frosina G.;
RT   "Predictability, efficacy and safety of radiosensitization of
RT   glioblastoma-initiating cells by the ATM inhibitor KU-60019.";
RL   Int. J. Cancer 135:479-491(2014).
//